The structure of a product, isolated during the synthesis of the semisynthetic glycopeptide MDL 63,246, was elucidated on the basis of spectroscopic methods and proved to be a novel glycopeptide containing a 3-oxazolin-5-one ring between positions 36 and 38. Subjected to acid hydrolysis this compound gave the corresponding pseudo aglycone and aglycone derivatives which maintained the original oxazolinone structure. Tested for antibacterial activity, these compounds showed a moderate activity against Gram-positive and inactive against Gram-negative bacteria. acting I with PyBOP in the presence of two equivalents of triethylamine (TEA). After isolation, the structure of this compound was elucidated on the basis of a combination of 1H-NMR, 13C-NMR and fast atom bombardament spectroscopies. The results proved that this compound was the novel glycopeptide III (Fig. 1 ) which contains a 3-oxazolin-5-one ring between positions C-36 and C-38.
prepared
by reacting the 6B-decarboxy-6B-hydroxymethyl derivative of the natural glycopeptide A-409261) (I) with 3, 3-dimethylamino-1-propylamine (DMEPA) in
In the course of some preliminary laboratory trials, carried out to determine the best conditions for this reaction, the formation of a less polar by-product was constantly observed in those runs performed with less than two equivalents of DMEPA. The same compound acting I with PyBOP in the presence of two equivalents of triethylamine (TEA). After isolation, the structure of this compound was elucidated on the basis of a combination of 1H-NMR, 13C-NMR and fast atom bombardament spectroscopies. The results proved that this compound was the novel glycopeptide III (Fig. 1 ) which contains a 3-oxazolin-5-one ring between positions C-36 and C-38.
In this paper we report the synthesis and the structure elucidation of compound III, its physico-chemical properties and its two aglycones IV and V prepared by acidic hydrolysis of III in order to simplify the NMR spectra.
Tested for antibacterial activity, compounds III, IV and V, showed a moderate activity against Gram-positive bacteria some of which were clinically isolated resistant to teicoplanin.
Chemistry
By reacting compound I with two equivalents of DMEPA in dimethyl sulfoxide (DMSO) at room temperature in the presence of PyBOP an high yield of compound II is usually obtained. In this case, PyBOP reacts with compound I to form the corresponding benzotriazolyl ester Ia (Fig. 3) which reacting with DMEPA produced the dimethylaminopropylamide II (ammonolysis reaction).2) Gradually reducing the DMEPA/I molar ratio from 2 to 0.5, different mixtures of II and III were obtained in which the amount of compound III increased as the amount of DMEPA decreased. About 60% of III was obtained when 0.5 equivalents of DMEPA was used.
An explanation of these results can be given assuming that an intramolecular cyclization yielding the oxazolinone ring, gradually starts when less than two equivalents of DMEPA are available for the ammonolysis reaction.
In this case, the anion of the enolic form of the 36-amide group (1b) cyclized intramolecularly on the C=O of the benzotriazolyl ester producing the 2-oxazolin-5-one ring IIIa. This mechanism is analogous to that suggested for The potentiometric analysis of compound III performed in methyl cellosolve-water (4:1) and its insolubility in aqueous NaHCO3 solution indicated the absence of any carboxy group. The molecular weight was 1700.5 Daltons, by 18 Da less than the starting product, and the presence of a 1 784cm-1 band in the infrared spectrum characteristic of a 3-oxazolin-5-one system5) (III), suggested the presence of an oxazolinone ring. This value is significantly different from that expected for a 2-oxazolin-5-one system IIIa which is around 1 835cm-16).
1H -NMR Assignments
Proton resonances have been assigned by homonuclear proton resonance correlation spectroscopy using DQF-COSY7), TOCSY8) and NOESY9) experiments and HMQC10) spectra for proton carbon correlation via 1-J coupling.
The preliminary 1H-NMR analyses of compound III clearly indicated the presence of the long fatty acid chain and the sugar moieties.
In Table 2 the proton chemical shifts of compound V are compared with those of the A-40926 aglycone portion VIII. The proton chemical shifts, similar for the right part of the molecules, are significantly different in the left part where the oxazolinone ring is present. Analysing the DQF-COSY spectrum of aglycone V, it appears that one of the seven cross peaks, usually present in the amide proton/alpha proton region, is missing. The six cross while the signal for the last amino acid (w7/x7) is missing. An additional singlet, not present in the starting compound, that appears in the aromatic region is attributed to the oxazolone proton x7. The attribution of this proton was obtained by a NOESY experiment in which this proton experiences cross relaxation to x6 and z6.
It is noteworthy that the signals corresponding to 5b and 5f in the molecule containing the oxazolone ring experience a strong upfield shift with respect to the corresponding protons in VIII. This shift is interpretable as due to an anisotropic effect of the oxazolinone carbonyl moiety.
These results and the data obtained with the IR and mass spectroscopy analysis confirmed the presence of an oxazolinone ring. This hypothesis is also supported by the presence of an additional signal at 9.40ppm in the 1H -NMR spectrum of component V isolated as hydrochloride which can be attributed to the protonated nitrogen (NH+) of the oxazolone ring.
13C-NMR Assignments
A complete assignment of all carbon resonances of V has been achieved by HMQC and HMBC11) spectra. range correlations in the HMBC spectrum to the protons 7f and x7. Therefore it can be attributed to carbon C4 of the oxazolinone ring. The second carbon at 163.4 does not show any correlation and is assigned to be C5 (small 3J coupling constant to x7). It must be mentioned that also the carbon resonance of x7 does not experience any long range coupling to x6 (2J), z6 or w6 (3J). However, the 3J-coupling between the z6 carbon and the x7 proton is clearly observed and confirms the oxazolinone structure of III.
Antibacterial Activity
The biological activity data of compounds III, IV and v, tested against a panel of microorganisms in comparison with teicoplanin, are summarized in Table 3 . All three compounds showed moderate in vitro activity against Gram-positive bacteria and resulted inactive against Gram-negative bacteria. In particular, compound III showed an appreciable activity against Streptococcus pneumoniae UC41 and S. piogenes C203 (MIC 0.13 and 0.25 respectively) while compound V showed a good activity against isolates of S. aureus, Staphylococcus The resolution in the linear mode for this kind of compounds is R=270M/dM, with a mass accuracy of 0.04%. This accuracy is based on the calibration of the instrument at the start of each measurements with the singly charged protonated molecular ions produced from a standard mixture of dihydroxybenzoic acid (DHB), the undecapeptide substance P (MW 1347.6) and MDL 63,246 used as reference substance. varying the DMEPA/I molar ratio from 2 to 0.6 respectively.
Preparation of Compound III with TEA and PyBOP A 250ml round bottomed flask was charged with 80ml of DMSO, 8g of compound I (assay 83%; 3.9 mmoles) and 1.15ml of triethylamine (8.2 mmoles). The mixture was stirred at room temperature for 10 minutes then a solution of 2.7g of PyBOP (5.1 mmoles) in 10ml of DMSO was slowly added. Stirring was continued for additional 1.5 hours then the mixture was poured in 600ml of ethyl acetate. The suspension obtained was stirred for 30 minutes then the white solid was filtered and dried at room temperature yielding 9.2g of crude compound III. 
